Cytokinetics, Incorporated (CYTK)

Cytokinetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	46.89	113.02	65.58	112.67	82.99	36.43
Short-Term Investments	964.8	501.8	717	358.97	381.08	188.68
Cash & Short-Term Investments	1,012	614.82	782.58	471.64	464.06	225.11
Cash Growth	87.61%	-21.44%	65.93%	1.63%	106.15%	13.27%
Accounts Receivable	0.24	1.28	0.15	56.82	6.92	5.16
Receivables	0.24	1.28	0.15	56.82	6.92	5.16
Prepaid Expenses	6.67	11.94	12.46	7.22	3.24	3.48
Total Current Assets	1,019	628.05	795.19	535.67	474.22	233.75
Property, Plant & Equipment	140.57	147.74	163.19	146.41	16.27	13.41
Long-Term Investments	269.17	40.53	46.71	152.05	36.95	42.65
Other Long-Term Assets	7.73	8	9.69	7.19	6.36	-
Total Assets	1,436	824.32	1,015	841.32	533.8	289.81
Accounts Payable	11.58	21.51	25.61	21.09	8.05	8.16
Accrued Expenses	49.83	42.64	44.1	34.37	19.32	12.12
Current Portion of Long-Term Debt	11.52	10.08	0.96	-	-	-
Current Portion of Leases	18.86	18.88	12.83	14.86	2.79	4.62
Other Current Liabilities	18.03	9.57	1.12	1.54	1.05	1.12
Total Current Liabilities	109.81	102.68	84.62	71.86	31.2	26.02
Long-Term Debt	644.5	607.37	609.62	142.84	135.71	129.26
Long-Term Leases	114.75	120.58	126.9	112.23	0.44	2.2
Long-Term Unearned Revenue	448.51	379.98	300.5	266.07	253.07	143.28
Other Long-Term Liabilities	132.4	0.03	1.04	4.46	-	-
Total Liabilities	1,450	1,211	1,123	597.46	420.42	300.75
Common Stock	0.12	0.1	0.09	0.08	0.07	0.06
Additional Paid-In Capital	2,532	1,726	1,482	1,452	1,105	853.34
Retained Earnings	-2,552	-2,112	-1,586	-1,208	-992.31	-865.02
Comprehensive Income & Other	5.39	-0.01	-3.59	-0.87	0.15	0.68
Shareholders' Equity	-13.91	-386.32	-107.9	243.86	113.38	-10.94
Total Liabilities & Equity	1,436	824.32	1,015	841.32	533.8	289.81
Total Debt	789.63	756.91	750.3	269.93	138.94	136.07
Net Cash (Debt)	222.07	-142.09	32.28	201.71	325.12	89.04
Net Cash Growth	-	-	-84.00%	-37.96%	265.13%	-42.75%
Net Cash Per Share	2.07	-1.47	0.36	2.62	5.04	1.55
Filing Date Shares Outstanding	118.01	103	95.16	84.86	71.11	59.45
Total Common Shares Outstanding	117.89	101.64	94.83	84.8	71.02	59.17
Working Capital	908.79	525.37	710.57	463.81	443.02	207.73
Book Value Per Share	-0.12	-3.80	-1.14	2.88	1.60	-0.18
Tangible Book Value	-13.91	-386.32	-107.9	243.86	113.38	-10.94
Tangible Book Value Per Share	-0.12	-3.80	-1.14	2.88	1.60	-0.18
Machinery	-	28.16	28.45	27.48	22.99	23.5
Construction In Progress	-	0.22	0.74	0.22	9.13	-
Leasehold Improvements	-	66.87	65.91	60.34	5.87	5.22

Source: S&P Capital IQ. Standard template. Financial Sources.